Amgen Net Worth (Updated 2026).

Amgen, a biotechnology giant, was founded in 1980 by seven scientists who shared a vision to apply the latest advances in molecular biology to the treatment of human disease. They began their journey in a small laboratory in Thousand Oaks, California, with a focus on recombinant DNA technology, which allows for the production of human proteins using genetically engineered bacteria.

The company’s breakthrough came in 1983 when they developed Epogen, the world’s first recombinant human erythropoietin. This groundbreaking drug, used to treat anemia associated with kidney disease and other conditions, revolutionized the field of biotechnology and solidified Amgen’s reputation as a leader in the industry.

Amgen’s Current Net Worth (2025)

As of 2025, Amgen’s current net worth is estimated to be around $175 billion. This significant figure reflects the company’s robust financial health and its success in the biotechnology industry.

Amgen’s Career

Founded in 1980, Amgen has grown to become one of the world’s leading biotechnology companies. It’s known for its groundbreaking work in developing innovative medicines, with notable contributions in the areas of oncology, cardiovascular disease, and inflammation. Amgen’s commitment to scientific research and patient care has earned it a respected reputation in the pharmaceutical industry.

Amgen’s Other Ventures

Beyond its core business, Amgen is involved in various other ventures. These include collaborations with other pharmaceutical companies and academic institutions to advance research and development. Additionally, Amgen has a robust philanthropic arm, Amgen Foundation, which supports science education and health initiatives.

Amgen’s Assets

Amgen’s assets are primarily composed of its extensive portfolio of drugs, including blockbusters like Epogen, Neupogen, and Enbrel. The company also holds a significant amount of cash and cash equivalents, totaling over $30 billion as of 2021. Its intellectual property portfolio, consisting of patents and trademarks, is another substantial asset.

Amgen’s Annual Income

In 2021, Amgen reported total revenues of approximately $28 billion. This figure represents a steady increase from previous years, demonstrating the company’s consistent financial performance. Amgen’s annual income primarily comes from the global sales of its pharmaceutical products.

Frequently Asked Questions about  Amgen

Frequently Asked Questions: Amgen Net Worth

1. What is Amgen’s net worth?

Amgen’s net worth is estimated to be over $140 billion.

2. How does Amgen generate its revenue?

Amgen generates revenue through the sale of its pharmaceutical products, primarily in the areas of oncology, cardiovascular disease, inflammation, bone health, and neuroscience.

3. What are some of Amgen’s most popular drugs?

Some of Amgen’s most popular drugs include Enbrel (etanercept) for rheumatoid arthritis, Neulasta (pegfilgrastim) for neutropenia, and Prolia (denosumab) for osteoporosis. Additionally, Amgen’s cancer drugs like Imlygic (talimogene laherparepvec) for melanoma and Blincyto (blinatumomab) for acute lymphoblastic leukemia have gained significant attention.

4. When was Amgen founded?

Amgen was founded in 1980.

5. Who is the current CEO of Amgen?

The current CEO of Amgen is Robert A. Bradway.

6. Where is Amgen’s headquarters located?

Amgen’s headquarters is located in Thousand Oaks, California, United States.

7. How many employees does Amgen have?

As of 2021, Amgen has over 20,000 employees worldwide.

8. What is Amgen’s stock ticker symbol?

Amgen’s stock ticker symbol is AMGN on the NASDAQ stock exchange.

9. What is Amgen’s mission statement?

Amgen’s mission statement is “To serve patients by transforming medicine, one life at a time.”

10. How does Amgen contribute to society and the environment?

Amgen contributes to society through its commitment to developing innovative medicines and improving patient access. It also supports various community initiatives and environmental sustainability efforts, such as reducing its carbon footprint and promoting responsible water usage.